IRIS
Modica, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.616
NA - Nord America 3.621
EU - Europa 2.549
SA - Sud America 497
Continente sconosciuto - Info sul continente non disponibili 165
AF - Africa 107
OC - Oceania 5
AN - Antartide 1
Totale 11.561
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.437
SG - Singapore 2.003
RU - Federazione Russa 1.250
CN - Cina 1.059
VN - Vietnam 675
IT - Italia 487
BR - Brasile 378
HK - Hong Kong 336
DE - Germania 188
FR - Francia 167
CA - Canada 108
KR - Corea 107
NL - Olanda 98
GB - Regno Unito 88
IN - India 87
BD - Bangladesh 85
FI - Finlandia 76
JP - Giappone 76
AR - Argentina 50
CI - Costa d'Avorio 39
SE - Svezia 33
UA - Ucraina 33
MX - Messico 31
PL - Polonia 28
IQ - Iraq 24
ZA - Sudafrica 24
ES - Italia 23
PH - Filippine 23
CO - Colombia 22
ID - Indonesia 22
EC - Ecuador 17
IE - Irlanda 16
AT - Austria 15
TH - Thailandia 15
TR - Turchia 14
PK - Pakistan 11
MA - Marocco 10
TW - Taiwan 10
AZ - Azerbaigian 8
CZ - Repubblica Ceca 8
HN - Honduras 8
MY - Malesia 8
UZ - Uzbekistan 8
CL - Cile 7
CR - Costa Rica 7
JO - Giordania 7
VE - Venezuela 7
BE - Belgio 6
GT - Guatemala 6
KE - Kenya 6
LT - Lituania 6
EG - Egitto 5
JM - Giamaica 5
NP - Nepal 5
PE - Perù 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
HR - Croazia 4
KZ - Kazakistan 4
NI - Nicaragua 4
PS - Palestinian Territory 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
DZ - Algeria 3
RO - Romania 3
SA - Arabia Saudita 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BB - Barbados 2
BO - Bolivia 2
BW - Botswana 2
BY - Bielorussia 2
CG - Congo 2
CH - Svizzera 2
DM - Dominica 2
DO - Repubblica Dominicana 2
GI - Gibilterra 2
HU - Ungheria 2
KG - Kirghizistan 2
LY - Libia 2
MD - Moldavia 2
MZ - Mozambico 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BS - Bahamas 1
CM - Camerun 1
CY - Cipro 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
Totale 11.381
Salva come PNG Salva come JPEG
Città #
Singapore 1.074
San Jose 891
Hefei 490
Ashburn 379
Moscow 338
Hong Kong 323
Beijing 271
Ho Chi Minh City 215
Chandler 186
Santa Clara 178
Hanoi 155
Naples 123
Los Angeles 111
Council Bluffs 110
The Dalles 93
Lauterbourg 91
Seoul 89
Amsterdam 76
Tokyo 70
Munich 60
New York 58
Buffalo 49
Redondo Beach 43
Frankfurt am Main 42
Milan 38
Rome 38
São Paulo 37
Helsinki 36
Orem 36
Seattle 35
Kochi 32
Dallas 30
Phoenix 30
Boston 25
Düsseldorf 24
London 24
Turku 24
Millbury 23
Haiphong 22
Brooklyn 21
Chicago 20
Des Moines 20
Warsaw 20
Da Nang 19
Denver 19
Houston 19
Napoli 19
Jacksonville 18
Rio de Janeiro 18
Chennai 17
Mexico City 17
Ottawa 17
Lawrence 16
Toronto 16
Falkenstein 15
Nanjing 15
Nuremberg 15
Stockholm 15
Washington 15
Atlanta 14
Montreal 14
Poplar 13
Princeton 13
San Francisco 13
Wilmington 13
Dong Ket 12
Baghdad 11
Johannesburg 11
Lappeenranta 11
Portsmouth 11
Biên Hòa 10
Brasília 10
Dhaka 10
Hải Dương 10
Paris 10
Portici 10
Roubaix 10
Phủ Lý 9
Afragola 8
Buenos Aires 8
Charlotte 8
Kronberg 8
Manchester 8
Amman 7
Baku 7
Bexley 7
Bogotá 7
Bắc Giang 7
Campinas 7
Nanchang 7
Philadelphia 7
Porto Alegre 7
San José 7
Vienna 7
Bari 6
Brussels 6
Can Tho 6
Dublin 6
Guayaquil 6
Kuala Lumpur 6
Totale 6.688
Salva come PNG Salva come JPEG
Nome #
Vein wall thickness and severity of pulmonary involvement due to sars n-cov2 virus infection 202
Emerging therapies in pheochromocytoma and paraganglioma: Immune checkpoint inhibitors in the starting blocks 189
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective 181
Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives 169
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication. 168
Hepatic arterial embolization in patients with neuroendocrine tumors. 165
Pituitary function and morphology in Fabry disease. 164
Open issues on G3 neuroendocrine neoplasms: Back to the future 162
Quality of life in patients with neuroendocrine neoplasms: The role of severity, clinical heterogeneity and resilience 161
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? 161
GLP-1: benefits beyond pancreas. 160
Bone metastases in neuroendocrine neoplasms: From pathogenesis to clinical management 158
Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib 157
Immune checkpoint blockade for Merkel cell carcinoma: actual findings and unanswered questions 153
Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis 151
A Multicenter Epidemiological Study on Second Malignancy in Non-Syndromic Pheochromocytoma/Paraganglioma Patients in Italy 148
A rare rarity: Neuroendocrine tumor of the esophagus 142
Lanreotide therapy vs active surveillance in MEN1-related pancreatic neuroendocrine tumors <2 cm 142
Vitamin D deficiency and tumor aggressiveness in gastroenteropancreatic neuroendocrine tumors 142
Diagnosis of Flier’s syndrome in a patient with nondiabetic hypoglycemia: a case report and critical appraisal of the literature 140
Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors 138
Nutrition and neuroendocrine tumors: An update of the literature. 138
Targeting neuroendocrine tumors with octreotide and lanreotide: Key points for clinical practice from NET specialists 134
Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study 131
Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies (Oct, 10.1007/s40618-022-01905-4, 2022) 130
The safety of available treatments options for neuroendocrine tumors 128
An incidental rectal neuroendocrine microcarcinoma ('micro-NEC') coexistent with a high grade adenoma 126
The antiproliferative effect of pasireotide LAR alone and in combination with everolimus in patients with medullary thyroid cancer: a single-center, open-label, phase II, proof-of-concept study 125
Neuroendocrine Tumors and Survival Rates in Multiple Endocrine Neoplasia Type 1 Patients: Impact of Gender Difference 123
MR imaging characterization of pheochromocytoma: a comparison between typical and atypical tumor lesions 123
Recent advances and future challenges in the diagnosis of neuroendocrine neoplasms 123
Evaluation of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Systemic Immune–Inflammation Index (SII) as Potential Biomarkers in Patients with Sporadic Medullary Thyroid Cancer (MTC) 122
Health-related quality of life in patients with neuroendocrine neoplasms: a two-wave longitudinal study 122
Current understanding of pathogenetic mechanisms in neuroendocrine neoplasms 121
Pancreatic Neuroendocrine Tumors in patients with Multiple Endocrine Neoplasia Type 1: Diagnostic Value of Different MRI Sequences 121
Role of Metformin on Recurrence-Free Survival in Neuroendocrine Tumors 120
Neuroendocrine Neoplasms 119
Therapeutic strategies for patients with neuroendocrine neoplasms: current perspectives 119
Vitamin D and Bone Metabolism in Adult Patients with Neurofibromatosis Type 1 119
Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic Target 117
Cardiac mechanical synchrony couples with myocardial sympathetic innervation. A retrospective study with novel echocardiographic assessment in patients with 123I-mIBG imaging 116
Gestione integrata del tumore della prostata: il ruolo dell’endocrinologo 114
Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus 114
Nuove strategie terapeutiche per il trattamento dei NET 112
Complete clinical and biochemical control with cabergoline and octreotide in a patient with ectopic ACTH syndrome before surgery 112
Prognostic significance of laterality in lung neuroendocrine tumors 111
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons 111
Risk factors for gastroenteropancreatic neuroendocrine neoplasms ({GEP}-{NENs}): a three-centric case{\textendash}control study 111
Neuroendocrine Tumors and Immune System 111
Efficacy and Safety of Everolimus in Extrapancreatic Neuroendocrine Tumor: A Comprehensive Review of Literature 111
Interventional cytopathologist can successfully combine ultrasonographical and microscopic skills to narrow the differential diagnosis in fine‐needle aspiration of neck paraganglioma 110
Parathyroid diseases and metabolic syndrome 110
ASO Visual Abstract: Radical Resection in Enteropancreatic Neuroendocrine Tumors-Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 109
Carcinoide timico in paziente affetta da sindrome da neoplasie endocrine multiple di tipo 1 (MEN1): ruolo dello screening radiologico e medico-nucleare 108
Characterization of Atypical Pheochromocytomas with Correlative MRI and Planar/Hybrid Radionuclide Imaging: A Preliminary Study 108
Role of Bone Metastases in Lung Neuroendocrine Neoplasms: Clinical Presentation, Treatment and Impact on Prognosis 108
Nonconventional Doses of Somatostatin Analogs in Patients with Progressing Well-Differentiated Neuroendocrine Tumor 107
Laryngeal Neuroendocrine Tumor With Elevated Serum Calcitonin: A Diagnostic and Therapeutic Challenge. Case Report and Review of Literature 107
Selpercatinib e carcinoma midollare della tiroide 106
Therapeutic sequences in patients with grade 1−2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group 106
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) 105
Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors 105
Endocrine-disrupting chemicals (EDCs) and cancer: new perspectives on an old relationship 104
PRRT: identikit of the perfect patient 102
Radical Resection in Entero-Pancreatic Neuroendocrine Tumors: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 102
Natural History and Management of Familial Paraganglioma Syndrome Type 1: Long-Term Data from a Large Family 102
Erratum to: GLP-1: Benefits beyond pancreas 101
Corrigendum to: Quality of Life in Patients with Neuroendocrine Neoplasms: The Role of Severity, Clinical Heterogeneity, and Resilience (vol 106, pg e316, 2020) 100
Sunitinib nei feocromocitomi e paragangliomi 98
Bone metabolism and vitamin D implication in gastroenteropancreatic neuroendocrine tumors 98
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 97
Endocrine Pathology 97
What Lies behind Paraneoplastic Hypercalcemia Secondary to Well-Differentiated Neuroendocrine Neoplasms? A Systematic Review of the Literature 95
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 94
Assessment of the Risk of Nodal Involvement in Rectal Neuroendocrine Neoplasms: The NOVARA Score, a Multicentre Retrospective Study 92
Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches 92
Gender Differences in Lung Neuroendocrine Tumors: A Single-Center Experience 91
A new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase II trial 91
Recurrence-Free Survival in Early and Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung after Complete Tumor Resection 91
Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms 90
Impact of dyslipidemia and lipid‐lowering therapy with statins in patients with neuroendocrine tumors 86
Calcium-stimulated calcitonin test for the diagnosis of medullary thyroid cancer: results of a multicenter study and comparison between different assays 85
Chronotype: what role in the context of gastroenteropancreatic neuroendocrine tumors? 85
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study 82
Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers 82
No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus 79
Gender perspective in Lung Neuroendocrine Tumors: a critical review 78
Editorial: Neuroendocrine tumors: the road to precision medicine 76
Gastrinomas and non-functioning pancreatic endocrine tumors in multiple endocrine neoplasia syndrome type-1 (MEN-1) 75
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy 74
Thyroid transcription factor‐1 expression in lung neuroendocrine tumours: a gender-related biomarker? 73
Proteasome inhibitors in medullary thyroid carcinoma: time to restart with clinical trials? 71
Autoimmune polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) in Sicily: Confirmation that R203X is the peculiar AIRE gene mutation 70
Functioning neuroendocrine tumors (NET): Minimum requirements for a NET specialist 65
Metastasi ossee nei tumori neuroendocrini: presentazione clinica e terapia 64
Authorship of Italian medical literature on neuroendocrine neoplasms: any gender gap? 62
Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells? 62
Clinical presentation and recurrence of pituitary neuroendocrine tumors: results from a single referral center in Colombia 61
Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead 60
Gender impact on pancreatic neuroendocrine neoplasm (PanNEN) prognosis according to survival nomograms 59
Totale 11.312
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.748
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.748
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022213 0 0 25 3 5 14 1 6 17 16 64 62
2022/2023494 31 57 14 39 51 41 54 33 50 81 41 2
2023/2024515 20 66 53 48 40 67 17 84 3 16 69 32
2024/20253.037 108 83 25 34 104 213 327 240 173 320 1.126 284
2025/20266.519 606 761 672 642 1.031 198 810 359 691 380 198 171
2026/2027546 138 281 127 0 0 0 0 0 0 0 0 0
Totale 11.561